Tekla Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Tekla Capital Management’s Portfolio BCRX Stock Details BCRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$3.55M	Hold
2023 Q1	$4.21M	Sell
2022 Q4	$7.72M	Buy
2022 Q3	$4.41M	Buy
2022 Q2	$2.94M	Buy
2022 Q1	$3.2M	Buy
2018 Q1	–	Sell
2017 Q4	$2.21M	Buy
2017 Q3	$1.69M	Buy